Efficacy of endostar in combination with concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of esophagus: A randomized, open-label, phase II trial

被引：0
|
作者：
Qi, Y. [1 ]
Shao, L. [1 ]
机构：
[1] Sun Yat Sen Univ, Radiat, Canc Ctr, Gansu Hosp, Lanzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.778
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
199P
引用
收藏
页码：S1551 / S1551
页数：1
相关论文
共 50 条
  • [31] Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial
    Jie Chen
    Chen Li
    Yuanjie Cao
    Li Zhu
    Bailin Zhang
    Jinqiang You
    Hailing Hou
    Jing Wang
    Zhiyong Yuan
    BMC Cancer, 22
  • [32] A phase I dose escalation study of Nimotuzumab in combination with concurrent chemoradiation for patients with locally advanced squamous cell carcinoma of esophagus
    Zhao, Kuai-le
    Hu, Xi-chun
    Wu, Xiang-hua
    Fu, Xiao-long
    Fan, Min
    Jiang, Guo-Liang
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1585 - 1590
  • [33] A phase I dose escalation study of Nimotuzumab in combination with concurrent chemoradiation for patients with locally advanced squamous cell carcinoma of esophagus
    Kuai-le Zhao
    Xi-chun Hu
    Xiang-hua Wu
    Xiao-long Fu
    Min Fan
    Guo-Liang Jiang
    Investigational New Drugs, 2012, 30 : 1585 - 1590
  • [34] A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx
    Huang, Pei-Wei
    Lin, Chien-Yu
    Hsieh, Chia-Hsun
    Hsu, Cheng-Lung
    Fan, Kang-Hsing
    Huang, Shiang-Fu
    Liao, Chun-Ta
    Ng, Shu-Kung
    Yen, Tzu-Chen
    Chang, Joseph Tung-Chieh
    Wang, Hung-Ming
    BIOMEDICAL JOURNAL, 2018, 41 (02) : 129 - 136
  • [35] Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A for Nonrandomized, Open-label, Phase II Trial
    Xu, Jianming
    Shen, Jie
    Gu, Shanzhi
    Zhang, Yun
    Wu, Lihua
    Wu, Jian
    Shao, Guoliang
    Zhang, Yanqiao
    Xu, Li
    Yin, Tao
    Liu, Jingfeng
    Ren, Zhenggang
    Xiong, Jianping
    Mao, Xianhai
    Zhang, Ling
    Yang, Jiayin
    Li, Lequn
    Chen, Xiaoming
    Wang, Zhiming
    Gu, Kangsheng
    Chen, Xi
    Pan, Zhanyu
    Ma, Kuansheng
    Zhou, Xinmin
    Yu, Zujiang
    Li, Enxiao
    Yin, Guowen
    Zhang, Xiao
    Wang, Shuni
    Wang, Quanren
    CLINICAL CANCER RESEARCH, 2021, 27 (04) : 1003 - 1011
  • [36] Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study
    Chen, Qiuyan
    Tang, Linquan
    Liu, Na
    Han, Feng
    Guo, Ling
    Guo, Shanshan
    Wang, Jianwei
    Liu, Huai
    Ye, Yanfang
    Zhang, Lu
    Liu, Liting
    Wang, Pan
    Li, Yingqin
    He, Qingmei
    Yang, Xiaoqun
    Tang, Qingnan
    Li, Yang
    Liang, YuJing
    Sun, XueSong
    Xie, Chuanmiao
    Mo, Yunxian
    Guo, Ying
    Sun, Rui
    Mo, Haoyuan
    Cao, Kajia
    Guo, Xiang
    Zeng, Musheng
    Mai, Haiqiang
    Ma, Jun
    CANCER COMMUNICATIONS, 2018, 38
  • [37] Camrelizumab in combination with preoperative chemotherapy for locally advanced esophageal squamous cell carcinoma: A single-arm, open-label, phase II study.
    Wang, Feng
    Qi, Yu
    Meng, Xiangrui
    Fan, Qingxia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial
    Liu, Yanxiao
    Zheng, Zhiyong
    Li, Minghao
    Zhang, Yaowen
    Zhao, Fujun
    Gong, Heyi
    Lin, Haiqun
    Huang, Wei
    Chen, Xiangming
    Xu, Zhiqiao
    Li, Xiaomin
    Liu, Wenzhi
    Cui, Yanhui
    Zheng, Anping
    Li, Baosheng
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (04) : 607 - 615
  • [39] A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC)
    Lee, S.
    Ahn, B. C.
    Park, S. Y.
    Kim, D. J.
    Lee, C. G.
    Cho, J.
    Kim, J. H.
    Kim, H. R.
    Kim, Y-H.
    Park, S. R.
    Chun, Y. J.
    Hong, M. H.
    Kim, H. R.
    Cho, B.
    ANNALS OF ONCOLOGY, 2019, 30
  • [40] A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC).
    Hong, Min Hee
    Kim, HyeRyun
    Park, Seong Yong
    Kim, Dae Joon
    Lee, Chang Geol
    Cho, Jaeho
    Kim, Jong Hoon
    Kim, Hyeong Ryul
    Kim, Yong-Hee
    Park, Sook Ryun
    Cho, Byoung Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345